149 related articles for article (PubMed ID: 6228528)
1. Echocardiographic left ventricular hypertrophy as related to arterial pressure and plasma norepinephrine concentration in arterial hypertension. Reversal by atenolol treatment.
Corea L; Bentivoglio M; Verdecchia P
Hypertension; 1983; 5(6):837-43. PubMed ID: 6228528
[TBL] [Abstract][Full Text] [Related]
2. Reversal of left ventricular hypertrophy after one-year treatment with clonidine: relationship between echocardiographic findings, blood pressure, and urinary catecholamines.
Timio M; Venanzi S; Gentili S; Ronconi M; Del Re G; Del Vita M
J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S142-6. PubMed ID: 2455168
[TBL] [Abstract][Full Text] [Related]
3. Participation of endogenous catecholamines in the regulation of left ventricular mass in progeny of hypertensive parents.
Trimarco B; Ricciardelli B; De Luca N; De Simone A; Cuocolo A; Galva MD; Picotti GB; Condorelli M
Circulation; 1985 Jul; 72(1):38-46. PubMed ID: 3159505
[TBL] [Abstract][Full Text] [Related]
4. Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension.
Thürmann PA; Kenedi P; Schmidt A; Harder S; Rietbrock N
Circulation; 1998 Nov; 98(19):2037-42. PubMed ID: 9808602
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular hypertrophy regression in hypertensive patients treated with metoprolol.
Corea L; Bentivoglio M; Verdecchia P; Provvidenza M; Motolese M
Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):365-70. PubMed ID: 6236155
[TBL] [Abstract][Full Text] [Related]
6. Regression of left ventricular hypertrophy during combined atenolol and nifedipine treatment.
Franz IW; Tönnesmann U; Behr U; Ketelhut R
Drugs; 1988; 35 Suppl 4():39-43. PubMed ID: 2967752
[TBL] [Abstract][Full Text] [Related]
7. [Regression of left ventricular mass in arterial hypertension. Efficacy of 3 different treatment protocols].
González-Juanatey JR; Amaro Cendón A; Calvo Gómez C; Vega Fernández M; García Acuña JM; Virgós Lamela A; Gil de la Peña M
Med Clin (Barc); 1992 Mar; 98(11):401-4. PubMed ID: 1533259
[TBL] [Abstract][Full Text] [Related]
8. Time course of regression of left ventricular hypertrophy in hypertensive patients treated with atenolol.
Dunn FG; Ventura HO; Messerli FH; Kobrin I; Frohlich ED
Circulation; 1987 Aug; 76(2):254-8. PubMed ID: 2955954
[TBL] [Abstract][Full Text] [Related]
9. ECG-gated cardiac scan and echocardiographic assessments of left ventricular hypertrophy: reversal by 6-month treatment with diltiazem.
Senda Y; Tohkai H; Kimura M; Shida Y; Tutumi S; Koshiyama H; Tanaka T; Shimaji Y; Nogita T
J Cardiovasc Pharmacol; 1990 Aug; 16(2):298-304. PubMed ID: 1697387
[TBL] [Abstract][Full Text] [Related]
10. Behavioral vs beta-blocker therapy in patients with primary hypertension: effects on blood pressure, left ventricular function and mass, and the pressor surge of social stress anger.
Lee DD; DeQuattro V; Allen J; Kimura S; Aleman E; Konugres G; Davison G
Am Heart J; 1988 Aug; 116(2 Pt 2):637-44. PubMed ID: 3293408
[TBL] [Abstract][Full Text] [Related]
11. Preserved ventricular pump function after a marked reduction of left ventricular mass.
Ketelhut R; Franz IW; Behr U; Toennesmann U; Messerli FH
J Am Coll Cardiol; 1992 Oct; 20(4):864-8. PubMed ID: 1356116
[TBL] [Abstract][Full Text] [Related]
12. [Association between blood pressure and circulating hormonal factors with left ventricular mass in patients with essential hypertension older than 55 years of age].
González Quijada S; Luque Otero M; Fernández-Cruz A; Almería C; Bagazgoitia Barrera J; Moya Marín FJ
Med Clin (Barc); 1997 Oct; 109(12):441-4. PubMed ID: 9441177
[TBL] [Abstract][Full Text] [Related]
13. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing cardiac hypertrophy in hypertensive patients.
Ibrahim MM; Madkour MA; Mossallam R
Clin Sci (Lond); 1981 Dec; 61 Suppl 7():105s-108s. PubMed ID: 6274563
[TBL] [Abstract][Full Text] [Related]
15. [Echocardiographic features of left ventricular hypertrophy and contractility in malignant hypertension].
Nakamura Y; Arita M; Fujiwara S; Tomobuchi Y; Nakamura H; Shiotani M; Yamamoto K; Ueno Y; Nishio I; Masuyama Y
J Cardiol; 1989 Mar; 19(1):125-34. PubMed ID: 2530333
[TBL] [Abstract][Full Text] [Related]
16. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
Devereux RB; Dahlöf B; Gerdts E; Boman K; Nieminen MS; Papademetriou V; Rokkedal J; Harris KE; Edelman JM; Wachtell K
Circulation; 2004 Sep; 110(11):1456-62. PubMed ID: 15326072
[TBL] [Abstract][Full Text] [Related]
17. Cardiac structural and functional changes during long-term antihypertensive treatment with lacidipine and atenolol in the European Lacidipine Study on Atherosclerosis (ELSA).
Agabiti-Rosei E; Trimarco B; Muiesan ML; Reid J; Salvetti A; Tang R; Hennig M; Baurecht H; Parati G; Mancia G; Zanchetti A;
J Hypertens; 2005 May; 23(5):1091-8. PubMed ID: 15834297
[TBL] [Abstract][Full Text] [Related]
18. Correlations between M-mode markers of left ventricular hypertrophy and radionuclide angiographic indices of left ventricular diastolic function in mild to moderate hypertension.
Granier P; Esquerre JP; Tredez P; Conte D; Bernadet P; Galinier F
J Hypertens Suppl; 1989 Dec; 7(6):S100-1. PubMed ID: 2534399
[TBL] [Abstract][Full Text] [Related]
19. Regression of left ventricular hypertrophy and systolic function in hypertensive patients during long-term treatment with ketanserin.
Coto V; Cocozza M; Oliviero U; Lucariello A; Picano T; Castaldo B; Iovino V; Cacciatore L
Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():77-80. PubMed ID: 2149516
[TBL] [Abstract][Full Text] [Related]
20. Plasma norepinephrine and left ventricular hypertrophy in systemic hypertension.
Corea L; Bentivoglio M; Verdecchia P; Motolese M
Am J Cardiol; 1984 May; 53(9):1299-303. PubMed ID: 6231849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
